Global GP681 Market Growth 2026-2032
The global GP681 market size is predicted to grow from US$ 34.24 million in 2025 to US$ 190 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.
GP681 is a novel oral antiviral drug targeting influenza viruses, belonging to the class of cap?dependent endonuclease inhibitors. It blocks the function of the polymerase acidic protein of influenza viruses, thereby inhibiting viral nucleic acid replication and transcription and rapidly controlling the infection process.
The drug features single?dose administration, rapid onset of action, and low incidence of drug resistance. It exhibits potent inhibitory activity against both influenza A and B viruses, and is clinically indicated for the treatment of influenza A and B in people aged 12 years and older.
With high safety and convenient administration, GP681 represents a typical domestically developed innovative anti?influenza drug, providing a new option for clinical influenza treatment.In 2025, global GP681 production reached approximately 1.2 million bottles
GP681 (Suraxavir) is China?s first domestically developed innovative anti-influenza drug targeting the PA protein. With its differentiated advantages of single-dose administration, rapid onset of action and low drug resistance rate, it has entered the domestic anti-influenza drug market worth tens of billions of yuan, breaking the monopoly of foreign products targeting the same site.
Its clinical data are all derived from Chinese populations, providing evidence more suitable for local patients. It demonstrates comparable efficacy and safety to international counterparts, with a significantly lower rate of drug resistance mutations, highlighting its prominent clinical value.
Currently dominated by oseltamivir and baloxavir, the market sees GP681 poised to rapidly penetrate hospital and retail channels and capture share in the PA inhibitor segment, backed by its status as a domestic innovative drug, pricing advantages and expected inclusion in medical insurance.
Meanwhile, the developer is expanding indications for children and high-risk populations and promoting overseas layout, further unlocking market potential and establishing GP681 as a representative breakthrough for domestic innovative drugs in the respiratory field.
LP Information, Inc. (LPI) ' newest research report, the ?GP681 Industry Forecast? looks at past sales and reviews total world GP681 sales in 2025, providing a comprehensive analysis by region and market sector of projected GP681 sales for 2026 through 2032. With GP681 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GP681 industry.
This Insight Report provides a comprehensive analysis of the global GP681 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GP681 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GP681 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GP681 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GP681.
This report presents a comprehensive overview, market shares, and growth opportunities of GP681 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global GP681 market?
What factors are driving GP681 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GP681 market opportunities vary by end market size?
How does GP681 break out by Type, by Application?
GP681 is a novel oral antiviral drug targeting influenza viruses, belonging to the class of cap?dependent endonuclease inhibitors. It blocks the function of the polymerase acidic protein of influenza viruses, thereby inhibiting viral nucleic acid replication and transcription and rapidly controlling the infection process.
The drug features single?dose administration, rapid onset of action, and low incidence of drug resistance. It exhibits potent inhibitory activity against both influenza A and B viruses, and is clinically indicated for the treatment of influenza A and B in people aged 12 years and older.
With high safety and convenient administration, GP681 represents a typical domestically developed innovative anti?influenza drug, providing a new option for clinical influenza treatment.In 2025, global GP681 production reached approximately 1.2 million bottles
GP681 (Suraxavir) is China?s first domestically developed innovative anti-influenza drug targeting the PA protein. With its differentiated advantages of single-dose administration, rapid onset of action and low drug resistance rate, it has entered the domestic anti-influenza drug market worth tens of billions of yuan, breaking the monopoly of foreign products targeting the same site.
Its clinical data are all derived from Chinese populations, providing evidence more suitable for local patients. It demonstrates comparable efficacy and safety to international counterparts, with a significantly lower rate of drug resistance mutations, highlighting its prominent clinical value.
Currently dominated by oseltamivir and baloxavir, the market sees GP681 poised to rapidly penetrate hospital and retail channels and capture share in the PA inhibitor segment, backed by its status as a domestic innovative drug, pricing advantages and expected inclusion in medical insurance.
Meanwhile, the developer is expanding indications for children and high-risk populations and promoting overseas layout, further unlocking market potential and establishing GP681 as a representative breakthrough for domestic innovative drugs in the respiratory field.
LP Information, Inc. (LPI) ' newest research report, the ?GP681 Industry Forecast? looks at past sales and reviews total world GP681 sales in 2025, providing a comprehensive analysis by region and market sector of projected GP681 sales for 2026 through 2032. With GP681 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GP681 industry.
This Insight Report provides a comprehensive analysis of the global GP681 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GP681 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GP681 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GP681 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GP681.
This report presents a comprehensive overview, market shares, and growth opportunities of GP681 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 20mg / ablet
- 40mg / ablet
- Adolescents Aged 12 Years And Above
- Adults
- Combined With Antipyretic And Analgesic Drugs
- Combined With Mucolytic And Antitussive Drugs
- Hospitals
- Retail
- Online
- Treatment of Influenza A
- Treatment of Influenza B
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qingfeng Pharmaceutical
- Jiangxi Kerui Pharmaceutical
- Yinxingshu Pharmaceutical
What is the 10-year outlook for the global GP681 market?
What factors are driving GP681 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GP681 market opportunities vary by end market size?
How does GP681 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GP681 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GP681 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GP681 by Country/Region, 2021, 2025 & 2032
2.2 GP681 Segment by Type
2.2.1 20mg / ablet
2.2.2 40mg / ablet
2.2.3 GP681 Sales by Type
2.2.3.1 Global GP681 Sales Market Share by Type (2021-2026)
2.2.3.2 Global GP681 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GP681 Sale Price by Type (2021-2026)
2.3 GP681 Segment by Target Population
2.3.1 Adolescents Aged 12 Years And Above
2.3.2 Adults
2.3.3 GP681 Sales by Target Population
2.3.3.1 Global GP681 Sales Market Share by Target Population (2021-2026)
2.3.3.2 Global GP681 Revenue and Market Share by Target Population (2021-2026)
2.3.3.3 Global GP681 Sale Price by Target Population (2021-2026)
2.4 GP681 Segment by Combination Medication
2.4.1 Combined With Antipyretic And Analgesic Drugs
2.4.2 Combined With Mucolytic And Antitussive Drugs
2.4.3 GP681 Sales by Combination Medication
2.4.3.1 Global GP681 Sales Market Share by Combination Medication (2021-2026)
2.4.3.2 Global GP681 Revenue and Market Share by Combination Medication (2021-2026)
2.4.3.3 Global GP681 Sale Price by Combination Medication (2021-2026)
2.5 GP681 Segment by Sales Channels
2.5.1 Hospitals
2.5.2 Retail
2.5.3 Online
2.5.4 GP681 Sales by Sales Channels
2.5.4.1 Global GP681 Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global GP681 Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global GP681 Sale Price by Sales Channels (2021-2026)
2.6 GP681 Segment by Application
2.6.1 Treatment of Influenza A
2.6.2 Treatment of Influenza B
2.6.3 Others
2.6.4 GP681 Sales by Application
2.6.4.1 Global GP681 Sale Market Share by Application (2021-2026)
2.6.4.2 Global GP681 Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global GP681 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GP681 Breakdown Data by Company
3.1.1 Global GP681 Annual Sales by Company (2021-2026)
3.1.2 Global GP681 Sales Market Share by Company (2021-2026)
3.2 Global GP681 Annual Revenue by Company (2021-2026)
3.2.1 Global GP681 Revenue by Company (2021-2026)
3.2.2 Global GP681 Revenue Market Share by Company (2021-2026)
3.3 Global GP681 Sale Price by Company
3.4 Key Manufacturers GP681 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GP681 Product Location Distribution
3.4.2 Players GP681 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GP681 BY GEOGRAPHIC REGION
4.1 World Historic GP681 Market Size by Geographic Region (2021-2026)
4.1.1 Global GP681 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GP681 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GP681 Market Size by Country/Region (2021-2026)
4.2.1 Global GP681 Annual Sales by Country/Region (2021-2026)
4.2.2 Global GP681 Annual Revenue by Country/Region (2021-2026)
4.3 Americas GP681 Sales Growth
4.4 APAC GP681 Sales Growth
4.5 Europe GP681 Sales Growth
4.6 Middle East & Africa GP681 Sales Growth
5 AMERICAS
5.1 Americas GP681 Sales by Country
5.1.1 Americas GP681 Sales by Country (2021-2026)
5.1.2 Americas GP681 Revenue by Country (2021-2026)
5.2 Americas GP681 Sales by Type (2021-2026)
5.3 Americas GP681 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GP681 Sales by Region
6.1.1 APAC GP681 Sales by Region (2021-2026)
6.1.2 APAC GP681 Revenue by Region (2021-2026)
6.2 APAC GP681 Sales by Type (2021-2026)
6.3 APAC GP681 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GP681 by Country
7.1.1 Europe GP681 Sales by Country (2021-2026)
7.1.2 Europe GP681 Revenue by Country (2021-2026)
7.2 Europe GP681 Sales by Type (2021-2026)
7.3 Europe GP681 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GP681 by Country
8.1.1 Middle East & Africa GP681 Sales by Country (2021-2026)
8.1.2 Middle East & Africa GP681 Revenue by Country (2021-2026)
8.2 Middle East & Africa GP681 Sales by Type (2021-2026)
8.3 Middle East & Africa GP681 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GP681
10.3 Manufacturing Process Analysis of GP681
10.4 Industry Chain Structure of GP681
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GP681 Distributors
11.3 GP681 Customer
12 WORLD FORECAST REVIEW FOR GP681 BY GEOGRAPHIC REGION
12.1 Global GP681 Market Size Forecast by Region
12.1.1 Global GP681 Forecast by Region (2027-2032)
12.1.2 Global GP681 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GP681 Forecast by Type (2027-2032)
12.7 Global GP681 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Qingfeng Pharmaceutical
13.1.1 Qingfeng Pharmaceutical Company Information
13.1.2 Qingfeng Pharmaceutical GP681 Product Portfolios and Specifications
13.1.3 Qingfeng Pharmaceutical GP681 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Qingfeng Pharmaceutical Main Business Overview
13.1.5 Qingfeng Pharmaceutical Latest Developments
13.2 Jiangxi Kerui Pharmaceutical
13.2.1 Jiangxi Kerui Pharmaceutical Company Information
13.2.2 Jiangxi Kerui Pharmaceutical GP681 Product Portfolios and Specifications
13.2.3 Jiangxi Kerui Pharmaceutical GP681 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangxi Kerui Pharmaceutical Main Business Overview
13.2.5 Jiangxi Kerui Pharmaceutical Latest Developments
13.3 Yinxingshu Pharmaceutical
13.3.1 Yinxingshu Pharmaceutical Company Information
13.3.2 Yinxingshu Pharmaceutical GP681 Product Portfolios and Specifications
13.3.3 Yinxingshu Pharmaceutical GP681 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Yinxingshu Pharmaceutical Main Business Overview
13.3.5 Yinxingshu Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GP681 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GP681 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GP681 by Country/Region, 2021, 2025 & 2032
2.2 GP681 Segment by Type
2.2.1 20mg / ablet
2.2.2 40mg / ablet
2.2.3 GP681 Sales by Type
2.2.3.1 Global GP681 Sales Market Share by Type (2021-2026)
2.2.3.2 Global GP681 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GP681 Sale Price by Type (2021-2026)
2.3 GP681 Segment by Target Population
2.3.1 Adolescents Aged 12 Years And Above
2.3.2 Adults
2.3.3 GP681 Sales by Target Population
2.3.3.1 Global GP681 Sales Market Share by Target Population (2021-2026)
2.3.3.2 Global GP681 Revenue and Market Share by Target Population (2021-2026)
2.3.3.3 Global GP681 Sale Price by Target Population (2021-2026)
2.4 GP681 Segment by Combination Medication
2.4.1 Combined With Antipyretic And Analgesic Drugs
2.4.2 Combined With Mucolytic And Antitussive Drugs
2.4.3 GP681 Sales by Combination Medication
2.4.3.1 Global GP681 Sales Market Share by Combination Medication (2021-2026)
2.4.3.2 Global GP681 Revenue and Market Share by Combination Medication (2021-2026)
2.4.3.3 Global GP681 Sale Price by Combination Medication (2021-2026)
2.5 GP681 Segment by Sales Channels
2.5.1 Hospitals
2.5.2 Retail
2.5.3 Online
2.5.4 GP681 Sales by Sales Channels
2.5.4.1 Global GP681 Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global GP681 Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global GP681 Sale Price by Sales Channels (2021-2026)
2.6 GP681 Segment by Application
2.6.1 Treatment of Influenza A
2.6.2 Treatment of Influenza B
2.6.3 Others
2.6.4 GP681 Sales by Application
2.6.4.1 Global GP681 Sale Market Share by Application (2021-2026)
2.6.4.2 Global GP681 Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global GP681 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GP681 Breakdown Data by Company
3.1.1 Global GP681 Annual Sales by Company (2021-2026)
3.1.2 Global GP681 Sales Market Share by Company (2021-2026)
3.2 Global GP681 Annual Revenue by Company (2021-2026)
3.2.1 Global GP681 Revenue by Company (2021-2026)
3.2.2 Global GP681 Revenue Market Share by Company (2021-2026)
3.3 Global GP681 Sale Price by Company
3.4 Key Manufacturers GP681 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GP681 Product Location Distribution
3.4.2 Players GP681 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GP681 BY GEOGRAPHIC REGION
4.1 World Historic GP681 Market Size by Geographic Region (2021-2026)
4.1.1 Global GP681 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GP681 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GP681 Market Size by Country/Region (2021-2026)
4.2.1 Global GP681 Annual Sales by Country/Region (2021-2026)
4.2.2 Global GP681 Annual Revenue by Country/Region (2021-2026)
4.3 Americas GP681 Sales Growth
4.4 APAC GP681 Sales Growth
4.5 Europe GP681 Sales Growth
4.6 Middle East & Africa GP681 Sales Growth
5 AMERICAS
5.1 Americas GP681 Sales by Country
5.1.1 Americas GP681 Sales by Country (2021-2026)
5.1.2 Americas GP681 Revenue by Country (2021-2026)
5.2 Americas GP681 Sales by Type (2021-2026)
5.3 Americas GP681 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GP681 Sales by Region
6.1.1 APAC GP681 Sales by Region (2021-2026)
6.1.2 APAC GP681 Revenue by Region (2021-2026)
6.2 APAC GP681 Sales by Type (2021-2026)
6.3 APAC GP681 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GP681 by Country
7.1.1 Europe GP681 Sales by Country (2021-2026)
7.1.2 Europe GP681 Revenue by Country (2021-2026)
7.2 Europe GP681 Sales by Type (2021-2026)
7.3 Europe GP681 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GP681 by Country
8.1.1 Middle East & Africa GP681 Sales by Country (2021-2026)
8.1.2 Middle East & Africa GP681 Revenue by Country (2021-2026)
8.2 Middle East & Africa GP681 Sales by Type (2021-2026)
8.3 Middle East & Africa GP681 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GP681
10.3 Manufacturing Process Analysis of GP681
10.4 Industry Chain Structure of GP681
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GP681 Distributors
11.3 GP681 Customer
12 WORLD FORECAST REVIEW FOR GP681 BY GEOGRAPHIC REGION
12.1 Global GP681 Market Size Forecast by Region
12.1.1 Global GP681 Forecast by Region (2027-2032)
12.1.2 Global GP681 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GP681 Forecast by Type (2027-2032)
12.7 Global GP681 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Qingfeng Pharmaceutical
13.1.1 Qingfeng Pharmaceutical Company Information
13.1.2 Qingfeng Pharmaceutical GP681 Product Portfolios and Specifications
13.1.3 Qingfeng Pharmaceutical GP681 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Qingfeng Pharmaceutical Main Business Overview
13.1.5 Qingfeng Pharmaceutical Latest Developments
13.2 Jiangxi Kerui Pharmaceutical
13.2.1 Jiangxi Kerui Pharmaceutical Company Information
13.2.2 Jiangxi Kerui Pharmaceutical GP681 Product Portfolios and Specifications
13.2.3 Jiangxi Kerui Pharmaceutical GP681 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangxi Kerui Pharmaceutical Main Business Overview
13.2.5 Jiangxi Kerui Pharmaceutical Latest Developments
13.3 Yinxingshu Pharmaceutical
13.3.1 Yinxingshu Pharmaceutical Company Information
13.3.2 Yinxingshu Pharmaceutical GP681 Product Portfolios and Specifications
13.3.3 Yinxingshu Pharmaceutical GP681 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Yinxingshu Pharmaceutical Main Business Overview
13.3.5 Yinxingshu Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GP681 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GP681 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 20mg / ablet
Table 4. Major Players of 40mg / ablet
Table 5. Global GP681 Sales by Type (2021-2026) & (Units)
Table 6. Global GP681 Sales Market Share by Type (2021-2026)
Table 7. Global GP681 Revenue by Type (2021-2026) & ($ million)
Table 8. Global GP681 Revenue Market Share by Type (2021-2026)
Table 9. Global GP681 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Adolescents Aged 12 Years And Above
Table 11. Major Players of Adults
Table 12. Global GP681 Sales by Target Population (2021-2026) & (Units)
Table 13. Global GP681 Sales Market Share by Target Population (2021-2026)
Table 14. Global GP681 Revenue by Target Population (2021-2026) & ($ million)
Table 15. Global GP681 Revenue Market Share by Target Population (2021-2026)
Table 16. Global GP681 Sale Price by Target Population (2021-2026) & (US$/Unit)
Table 17. Major Players of Combined With Antipyretic And Analgesic Drugs
Table 18. Major Players of Combined With Mucolytic And Antitussive Drugs
Table 19. Global GP681 Sales by Combination Medication (2021-2026) & (Units)
Table 20. Global GP681 Sales Market Share by Combination Medication (2021-2026)
Table 21. Global GP681 Revenue by Combination Medication (2021-2026) & ($ million)
Table 22. Global GP681 Revenue Market Share by Combination Medication (2021-2026)
Table 23. Global GP681 Sale Price by Combination Medication (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospitals
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global GP681 Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global GP681 Sales Market Share by Sales Channels (2021-2026)
Table 29. Global GP681 Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global GP681 Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global GP681 Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global GP681 Sale by Application (2021-2026) & (Units)
Table 33. Global GP681 Sale Market Share by Application (2021-2026)
Table 34. Global GP681 Revenue by Application (2021-2026) & ($ million)
Table 35. Global GP681 Revenue Market Share by Application (2021-2026)
Table 36. Global GP681 Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global GP681 Sales by Company (2021-2026) & (Units)
Table 38. Global GP681 Sales Market Share by Company (2021-2026)
Table 39. Global GP681 Revenue by Company (2021-2026) & ($ millions)
Table 40. Global GP681 Revenue Market Share by Company (2021-2026)
Table 41. Global GP681 Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers GP681 Producing Area Distribution and Sales Area
Table 43. Players GP681 Products Offered
Table 44. GP681 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global GP681 Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global GP681 Sales Market Share Geographic Region (2021-2026)
Table 49. Global GP681 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global GP681 Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global GP681 Sales by Country/Region (2021-2026) & (Units)
Table 52. Global GP681 Sales Market Share by Country/Region (2021-2026)
Table 53. Global GP681 Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global GP681 Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas GP681 Sales by Country (2021-2026) & (Units)
Table 56. Americas GP681 Sales Market Share by Country (2021-2026)
Table 57. Americas GP681 Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas GP681 Sales by Type (2021-2026) & (Units)
Table 59. Americas GP681 Sales by Application (2021-2026) & (Units)
Table 60. APAC GP681 Sales by Region (2021-2026) & (Units)
Table 61. APAC GP681 Sales Market Share by Region (2021-2026)
Table 62. APAC GP681 Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC GP681 Sales by Type (2021-2026) & (Units)
Table 64. APAC GP681 Sales by Application (2021-2026) & (Units)
Table 65. Europe GP681 Sales by Country (2021-2026) & (Units)
Table 66. Europe GP681 Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe GP681 Sales by Type (2021-2026) & (Units)
Table 68. Europe GP681 Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa GP681 Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa GP681 Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa GP681 Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa GP681 Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of GP681
Table 74. Key Market Challenges & Risks of GP681
Table 75. Key Industry Trends of GP681
Table 76. GP681 Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. GP681 Distributors List
Table 79. GP681 Customer List
Table 80. Global GP681 Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global GP681 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas GP681 Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas GP681 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC GP681 Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC GP681 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe GP681 Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe GP681 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa GP681 Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa GP681 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global GP681 Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global GP681 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global GP681 Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global GP681 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Qingfeng Pharmaceutical Basic Information, GP681 Manufacturing Base, Sales Area and Its Competitors
Table 95. Qingfeng Pharmaceutical GP681 Product Portfolios and Specifications
Table 96. Qingfeng Pharmaceutical GP681 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Qingfeng Pharmaceutical Main Business
Table 98. Qingfeng Pharmaceutical Latest Developments
Table 99. Jiangxi Kerui Pharmaceutical Basic Information, GP681 Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangxi Kerui Pharmaceutical GP681 Product Portfolios and Specifications
Table 101. Jiangxi Kerui Pharmaceutical GP681 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Jiangxi Kerui Pharmaceutical Main Business
Table 103. Jiangxi Kerui Pharmaceutical Latest Developments
Table 104. Yinxingshu Pharmaceutical Basic Information, GP681 Manufacturing Base, Sales Area and Its Competitors
Table 105. Yinxingshu Pharmaceutical GP681 Product Portfolios and Specifications
Table 106. Yinxingshu Pharmaceutical GP681 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Yinxingshu Pharmaceutical Main Business
Table 108. Yinxingshu Pharmaceutical Latest Developments
Table 1. GP681 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GP681 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 20mg / ablet
Table 4. Major Players of 40mg / ablet
Table 5. Global GP681 Sales by Type (2021-2026) & (Units)
Table 6. Global GP681 Sales Market Share by Type (2021-2026)
Table 7. Global GP681 Revenue by Type (2021-2026) & ($ million)
Table 8. Global GP681 Revenue Market Share by Type (2021-2026)
Table 9. Global GP681 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Adolescents Aged 12 Years And Above
Table 11. Major Players of Adults
Table 12. Global GP681 Sales by Target Population (2021-2026) & (Units)
Table 13. Global GP681 Sales Market Share by Target Population (2021-2026)
Table 14. Global GP681 Revenue by Target Population (2021-2026) & ($ million)
Table 15. Global GP681 Revenue Market Share by Target Population (2021-2026)
Table 16. Global GP681 Sale Price by Target Population (2021-2026) & (US$/Unit)
Table 17. Major Players of Combined With Antipyretic And Analgesic Drugs
Table 18. Major Players of Combined With Mucolytic And Antitussive Drugs
Table 19. Global GP681 Sales by Combination Medication (2021-2026) & (Units)
Table 20. Global GP681 Sales Market Share by Combination Medication (2021-2026)
Table 21. Global GP681 Revenue by Combination Medication (2021-2026) & ($ million)
Table 22. Global GP681 Revenue Market Share by Combination Medication (2021-2026)
Table 23. Global GP681 Sale Price by Combination Medication (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospitals
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global GP681 Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global GP681 Sales Market Share by Sales Channels (2021-2026)
Table 29. Global GP681 Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global GP681 Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global GP681 Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global GP681 Sale by Application (2021-2026) & (Units)
Table 33. Global GP681 Sale Market Share by Application (2021-2026)
Table 34. Global GP681 Revenue by Application (2021-2026) & ($ million)
Table 35. Global GP681 Revenue Market Share by Application (2021-2026)
Table 36. Global GP681 Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global GP681 Sales by Company (2021-2026) & (Units)
Table 38. Global GP681 Sales Market Share by Company (2021-2026)
Table 39. Global GP681 Revenue by Company (2021-2026) & ($ millions)
Table 40. Global GP681 Revenue Market Share by Company (2021-2026)
Table 41. Global GP681 Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers GP681 Producing Area Distribution and Sales Area
Table 43. Players GP681 Products Offered
Table 44. GP681 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global GP681 Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global GP681 Sales Market Share Geographic Region (2021-2026)
Table 49. Global GP681 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global GP681 Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global GP681 Sales by Country/Region (2021-2026) & (Units)
Table 52. Global GP681 Sales Market Share by Country/Region (2021-2026)
Table 53. Global GP681 Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global GP681 Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas GP681 Sales by Country (2021-2026) & (Units)
Table 56. Americas GP681 Sales Market Share by Country (2021-2026)
Table 57. Americas GP681 Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas GP681 Sales by Type (2021-2026) & (Units)
Table 59. Americas GP681 Sales by Application (2021-2026) & (Units)
Table 60. APAC GP681 Sales by Region (2021-2026) & (Units)
Table 61. APAC GP681 Sales Market Share by Region (2021-2026)
Table 62. APAC GP681 Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC GP681 Sales by Type (2021-2026) & (Units)
Table 64. APAC GP681 Sales by Application (2021-2026) & (Units)
Table 65. Europe GP681 Sales by Country (2021-2026) & (Units)
Table 66. Europe GP681 Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe GP681 Sales by Type (2021-2026) & (Units)
Table 68. Europe GP681 Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa GP681 Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa GP681 Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa GP681 Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa GP681 Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of GP681
Table 74. Key Market Challenges & Risks of GP681
Table 75. Key Industry Trends of GP681
Table 76. GP681 Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. GP681 Distributors List
Table 79. GP681 Customer List
Table 80. Global GP681 Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global GP681 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas GP681 Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas GP681 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC GP681 Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC GP681 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe GP681 Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe GP681 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa GP681 Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa GP681 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global GP681 Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global GP681 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global GP681 Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global GP681 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Qingfeng Pharmaceutical Basic Information, GP681 Manufacturing Base, Sales Area and Its Competitors
Table 95. Qingfeng Pharmaceutical GP681 Product Portfolios and Specifications
Table 96. Qingfeng Pharmaceutical GP681 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Qingfeng Pharmaceutical Main Business
Table 98. Qingfeng Pharmaceutical Latest Developments
Table 99. Jiangxi Kerui Pharmaceutical Basic Information, GP681 Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangxi Kerui Pharmaceutical GP681 Product Portfolios and Specifications
Table 101. Jiangxi Kerui Pharmaceutical GP681 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Jiangxi Kerui Pharmaceutical Main Business
Table 103. Jiangxi Kerui Pharmaceutical Latest Developments
Table 104. Yinxingshu Pharmaceutical Basic Information, GP681 Manufacturing Base, Sales Area and Its Competitors
Table 105. Yinxingshu Pharmaceutical GP681 Product Portfolios and Specifications
Table 106. Yinxingshu Pharmaceutical GP681 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Yinxingshu Pharmaceutical Main Business
Table 108. Yinxingshu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of GP681
Figure 2. GP681 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GP681 Sales Growth Rate 2021-2032 (Units)
Figure 7. Global GP681 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GP681 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GP681 Sales Market Share by Country/Region (2025)
Figure 10. GP681 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 20mg / ablet
Figure 12. Product Picture of 40mg / ablet
Figure 13. Global GP681 Sales Market Share by Type in 2026
Figure 14. Global GP681 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Adolescents Aged 12 Years And Above
Figure 16. Product Picture of Adults
Figure 17. Global GP681 Sales Market Share by Target Population in 2026
Figure 18. Global GP681 Revenue Market Share by Target Population (2021-2026)
Figure 19. Product Picture of Combined With Antipyretic And Analgesic Drugs
Figure 20. Product Picture of Combined With Mucolytic And Antitussive Drugs
Figure 21. Global GP681 Sales Market Share by Combination Medication in 2026
Figure 22. Global GP681 Revenue Market Share by Combination Medication (2021-2026)
Figure 23. Product Picture of Hospitals
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global GP681 Sales Market Share by Sales Channels in 2026
Figure 27. Global GP681 Revenue Market Share by Sales Channels (2021-2026)
Figure 28. GP681 Consumed in Treatment of Influenza A
Figure 29. Global GP681 Market: Treatment of Influenza A (2021-2026) & (Units)
Figure 30. GP681 Consumed in Treatment of Influenza B
Figure 31. Global GP681 Market: Treatment of Influenza B (2021-2026) & (Units)
Figure 32. GP681 Consumed in Others
Figure 33. Global GP681 Market: Others (2021-2026) & (Units)
Figure 34. Global GP681 Sale Market Share by Application (2025)
Figure 35. Global GP681 Revenue Market Share by Application in 2025
Figure 36. GP681 Sales by Company in 2025 (Units)
Figure 37. Global GP681 Sales Market Share by Company in 2025
Figure 38. GP681 Revenue by Company in 2025 ($ millions)
Figure 39. Global GP681 Revenue Market Share by Company in 2025
Figure 40. Global GP681 Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global GP681 Revenue Market Share by Geographic Region in 2025
Figure 42. Americas GP681 Sales 2021-2026 (Units)
Figure 43. Americas GP681 Revenue 2021-2026 ($ millions)
Figure 44. APAC GP681 Sales 2021-2026 (Units)
Figure 45. APAC GP681 Revenue 2021-2026 ($ millions)
Figure 46. Europe GP681 Sales 2021-2026 (Units)
Figure 47. Europe GP681 Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa GP681 Sales 2021-2026 (Units)
Figure 49. Middle East & Africa GP681 Revenue 2021-2026 ($ millions)
Figure 50. Americas GP681 Sales Market Share by Country in 2025
Figure 51. Americas GP681 Revenue Market Share by Country (2021-2026)
Figure 52. Americas GP681 Sales Market Share by Type (2021-2026)
Figure 53. Americas GP681 Sales Market Share by Application (2021-2026)
Figure 54. United States GP681 Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada GP681 Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico GP681 Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil GP681 Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC GP681 Sales Market Share by Region in 2025
Figure 59. APAC GP681 Revenue Market Share by Region (2021-2026)
Figure 60. APAC GP681 Sales Market Share by Type (2021-2026)
Figure 61. APAC GP681 Sales Market Share by Application (2021-2026)
Figure 62. China GP681 Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan GP681 Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea GP681 Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia GP681 Revenue Growth 2021-2026 ($ millions)
Figure 66. India GP681 Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia GP681 Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan GP681 Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe GP681 Sales Market Share by Country in 2025
Figure 70. Europe GP681 Revenue Market Share by Country (2021-2026)
Figure 71. Europe GP681 Sales Market Share by Type (2021-2026)
Figure 72. Europe GP681 Sales Market Share by Application (2021-2026)
Figure 73. Germany GP681 Revenue Growth 2021-2026 ($ millions)
Figure 74. France GP681 Revenue Growth 2021-2026 ($ millions)
Figure 75. UK GP681 Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy GP681 Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia GP681 Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa GP681 Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa GP681 Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa GP681 Sales Market Share by Application (2021-2026)
Figure 81. Egypt GP681 Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa GP681 Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel GP681 Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey GP681 Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries GP681 Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of GP681 in 2026
Figure 87. Manufacturing Process Analysis of GP681
Figure 88. Industry Chain Structure of GP681
Figure 89. Channels of Distribution
Figure 90. Global GP681 Sales Market Forecast by Region (2027-2032)
Figure 91. Global GP681 Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global GP681 Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global GP681 Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global GP681 Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global GP681 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of GP681
Figure 2. GP681 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GP681 Sales Growth Rate 2021-2032 (Units)
Figure 7. Global GP681 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GP681 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GP681 Sales Market Share by Country/Region (2025)
Figure 10. GP681 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 20mg / ablet
Figure 12. Product Picture of 40mg / ablet
Figure 13. Global GP681 Sales Market Share by Type in 2026
Figure 14. Global GP681 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Adolescents Aged 12 Years And Above
Figure 16. Product Picture of Adults
Figure 17. Global GP681 Sales Market Share by Target Population in 2026
Figure 18. Global GP681 Revenue Market Share by Target Population (2021-2026)
Figure 19. Product Picture of Combined With Antipyretic And Analgesic Drugs
Figure 20. Product Picture of Combined With Mucolytic And Antitussive Drugs
Figure 21. Global GP681 Sales Market Share by Combination Medication in 2026
Figure 22. Global GP681 Revenue Market Share by Combination Medication (2021-2026)
Figure 23. Product Picture of Hospitals
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global GP681 Sales Market Share by Sales Channels in 2026
Figure 27. Global GP681 Revenue Market Share by Sales Channels (2021-2026)
Figure 28. GP681 Consumed in Treatment of Influenza A
Figure 29. Global GP681 Market: Treatment of Influenza A (2021-2026) & (Units)
Figure 30. GP681 Consumed in Treatment of Influenza B
Figure 31. Global GP681 Market: Treatment of Influenza B (2021-2026) & (Units)
Figure 32. GP681 Consumed in Others
Figure 33. Global GP681 Market: Others (2021-2026) & (Units)
Figure 34. Global GP681 Sale Market Share by Application (2025)
Figure 35. Global GP681 Revenue Market Share by Application in 2025
Figure 36. GP681 Sales by Company in 2025 (Units)
Figure 37. Global GP681 Sales Market Share by Company in 2025
Figure 38. GP681 Revenue by Company in 2025 ($ millions)
Figure 39. Global GP681 Revenue Market Share by Company in 2025
Figure 40. Global GP681 Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global GP681 Revenue Market Share by Geographic Region in 2025
Figure 42. Americas GP681 Sales 2021-2026 (Units)
Figure 43. Americas GP681 Revenue 2021-2026 ($ millions)
Figure 44. APAC GP681 Sales 2021-2026 (Units)
Figure 45. APAC GP681 Revenue 2021-2026 ($ millions)
Figure 46. Europe GP681 Sales 2021-2026 (Units)
Figure 47. Europe GP681 Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa GP681 Sales 2021-2026 (Units)
Figure 49. Middle East & Africa GP681 Revenue 2021-2026 ($ millions)
Figure 50. Americas GP681 Sales Market Share by Country in 2025
Figure 51. Americas GP681 Revenue Market Share by Country (2021-2026)
Figure 52. Americas GP681 Sales Market Share by Type (2021-2026)
Figure 53. Americas GP681 Sales Market Share by Application (2021-2026)
Figure 54. United States GP681 Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada GP681 Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico GP681 Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil GP681 Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC GP681 Sales Market Share by Region in 2025
Figure 59. APAC GP681 Revenue Market Share by Region (2021-2026)
Figure 60. APAC GP681 Sales Market Share by Type (2021-2026)
Figure 61. APAC GP681 Sales Market Share by Application (2021-2026)
Figure 62. China GP681 Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan GP681 Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea GP681 Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia GP681 Revenue Growth 2021-2026 ($ millions)
Figure 66. India GP681 Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia GP681 Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan GP681 Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe GP681 Sales Market Share by Country in 2025
Figure 70. Europe GP681 Revenue Market Share by Country (2021-2026)
Figure 71. Europe GP681 Sales Market Share by Type (2021-2026)
Figure 72. Europe GP681 Sales Market Share by Application (2021-2026)
Figure 73. Germany GP681 Revenue Growth 2021-2026 ($ millions)
Figure 74. France GP681 Revenue Growth 2021-2026 ($ millions)
Figure 75. UK GP681 Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy GP681 Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia GP681 Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa GP681 Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa GP681 Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa GP681 Sales Market Share by Application (2021-2026)
Figure 81. Egypt GP681 Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa GP681 Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel GP681 Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey GP681 Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries GP681 Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of GP681 in 2026
Figure 87. Manufacturing Process Analysis of GP681
Figure 88. Industry Chain Structure of GP681
Figure 89. Channels of Distribution
Figure 90. Global GP681 Sales Market Forecast by Region (2027-2032)
Figure 91. Global GP681 Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global GP681 Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global GP681 Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global GP681 Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global GP681 Revenue Market Share Forecast by Application (2027-2032)
